Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.01%Gross Profits to Assets
VS
Market
Sector
Industry
History
$ 17.32Close
$ 7.8 - $ 29.6 52-Week Range
Ticker Information
Ticker
LYELCompany Name
LYELL IMMUNOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQLYELL IMMUNOPHARMA INC - Gross Profits to Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
LYEL - GPA Historical data
| Date | Total Assets | Gross Profit | Gross Profits to Assets |
|---|---|---|---|
| 6/30/2025 | $ 385.45M | $ 53K | 0.01% |
| 3/31/2025 | $ 429.8M | $ 58K | 0.01% |
| 12/31/2024 | $ 490.86M | $ 61K | 0.01% |
| 9/30/2024 | $ 619.22M | $ 63K | 0.01% |
| 6/30/2024 | $ 654.14M | $ 54K | 0.01% |
| 3/31/2024 | $ 694.22M | $ 68K | 0.01% |
| 12/31/2023 | $ 750.03M | $ 130K | 0.02% |
| 9/30/2023 | $ 794.99M | $ 48.5M | 6.1% |
| 6/30/2023 | $ 835.35M | $ 48.48M | 5.8% |
| 3/31/2023 | $ 880.45M | $ 84.19M | 9.56% |
Key Performance Insights, Last 5 Years
- LYELL IMMUNOPHARMA INC's latest trailing twelve months (TTM) GPA stands at 0.85%.
- Over the past 5 years, LYELL IMMUNOPHARMA INC's average GPA has been 2.58%.
- The median GPA for LYELL IMMUNOPHARMA INC during this period was 0.84%
- LYELL IMMUNOPHARMA INC reached its highest GPA over the past 5 years at 9.56%.
- The lowest GPA recorded by LYELL IMMUNOPHARMA INC in the same timeframe 0.01%
LYELL IMMUNOPHARMA INC's GPA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GPA Benchmarks
Similar metrics to GPA:
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Asset Turnover - [Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Gross Profit - [Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Definition of Gross Profits to Assets
[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].GP / Assets
(=) GPA GPA for LYELL IMMUNOPHARMA INC is calculated as follows: GP [ $ 7.76M ] / Assets [ $ 908.28M ]
(=) GPA [ 0.85% ] LYEL - Gross Profits to Assets, Last 5 years
0.01%
Minimum
Jun 30, 2024
9.56%
Maximum
Mar 31, 2023
2.58%
Average
0.84%
Median
GPA Benchmark AnalysisMarket
The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.15% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
| filtered constituents | 4.13K |
|---|---|
| min | -50.32% |
| max | 83.98% |
| average | 20.15% |
| median | 15.35% |
| std | 19.95% |